Related Experiment Video
Updated: Aug 13, 2026
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Antibody-based therapeutics: focus on prostate cancer
Jeffrey S Ross1, Karen E Gray, Iain J Webb
1Millennium Pharmaceuticals, Inc., Cambridge, MA, USA. rossj@mail.amc.edu
Cancer Metastasis Reviews
|January 13, 2006
Summary
Antibody therapeutics show promise for treating various cancers, including prostate cancer. These targeted treatments offer potential for lower toxicity and increased efficacy, both alone and in combination therapies.
Area of Science:
- Oncology
- Immunotherapy
- Pharmacology
Background:
- The success of existing antibody-based cancer drugs has spurred interest in antibody therapeutics.
- Antibodies offer potential for targeted cancer treatment with lower toxicity compared to traditional chemotherapy.
- Advancements in identifying cell surface targets are crucial for developing new antibody therapies.
Purpose of the Study:
- To explore the role of antibody therapeutics in treating hematopoietic malignancies and solid tumors.
- To investigate the potential of antibody conjugates for enhanced anti-cancer efficacy.
- To assess the clinical development and potential benefits of novel antibody agents for prostate cancer.
Main Methods:
- Review of clinical and commercial success of anti-cancer antibodies.
- Identification of cell surface targets for hormone-refractory prostate cancer.
- Analysis of preclinical and clinical development stages of antibody-based therapies.
Main Results:
- Antibody therapeutics are being developed for both hematopoietic malignancies and solid tumors.
- Conjugation of antibodies to radioisotopes or toxins may increase efficacy.
- Numerous antibody agents are progressing through preclinical and clinical development for prostate cancer.
Conclusions:
- Antibody therapeutics are expected to play a significant role in cancer treatment strategies.
- Further clinical evaluation is needed to determine the lasting benefits of antibody agents in prostate cancer.
- Combination therapy approaches involving antibodies hold promise for improved patient outcomes.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
10:47Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:20Immunoprecipitation
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...